IDEANOMICS INC (IDEX) Fundamental Analysis & Valuation

NASDAQ:IDEX • US45166V2051

Current stock price

0.88 USD
-0.04 (-4.36%)
At close:
0.634 USD
-0.25 (-27.95%)
After Hours:

This IDEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IDEX Profitability Analysis

1.1 Basic Checks

  • IDEX had negative earnings in the past year.
  • In the past year IDEX has reported a negative cash flow from operations.
  • In the past 5 years IDEX always reported negative net income.
  • IDEX had a negative operating cash flow in each of the past 5 years.
IDEX Yearly Net Income VS EBIT VS OCF VS FCFIDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M -200M -250M

1.2 Ratios

  • The Return On Assets of IDEX (-191.90%) is worse than 97.69% of its industry peers.
Industry RankSector Rank
ROA -191.9%
ROE N/A
ROIC N/A
ROA(3y)-117.79%
ROA(5y)-94.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IDEX Yearly ROA, ROE, ROICIDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

  • IDEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IDEX Yearly Profit, Operating, Gross MarginsIDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

0

2. IDEX Health Analysis

2.1 Basic Checks

  • IDEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IDEX has been increased compared to 1 year ago.
  • IDEX has a worse debt/assets ratio than last year.
IDEX Yearly Shares OutstandingIDEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
IDEX Yearly Total Debt VS Total AssetsIDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -16.65, we must say that IDEX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -16.65, IDEX is doing worse than 96.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -16.65
ROIC/WACCN/A
WACC6.47%
IDEX Yearly LT Debt VS Equity VS FCFIDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.28 indicates that IDEX may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.28, IDEX is doing worse than 98.46% of the companies in the same industry.
  • IDEX has a Quick Ratio of 0.28. This is a bad value and indicates that IDEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IDEX has a Quick ratio of 0.11. This is amonst the worse of the industry: IDEX underperforms 97.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.11
IDEX Yearly Current Assets VS Current LiabilitesIDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

0

3. IDEX Growth Analysis

3.1 Past

  • IDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.75%, which is quite impressive.
  • Looking at the last year, IDEX shows a very negative growth in Revenue. The Revenue has decreased by -65.32% in the last year.
  • IDEX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -47.23% yearly.
EPS 1Y (TTM)64.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.11%
Revenue 1Y (TTM)-65.32%
Revenue growth 3Y-16.76%
Revenue growth 5Y-47.23%
Sales Q2Q%-77.68%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y58.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year74.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IDEX Yearly Revenue VS EstimatesIDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
IDEX Yearly EPS VS EstimatesIDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2021 2022 2023 2024 -20 -40 -60

0

4. IDEX Valuation Analysis

4.1 Price/Earnings Ratio

  • IDEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IDEX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IDEX Price Earnings VS Forward Price EarningsIDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IDEX Per share dataIDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. IDEX Dividend Analysis

5.1 Amount

  • No dividends for IDEX!.
Industry RankSector Rank
Dividend Yield N/A

IDEX Fundamentals: All Metrics, Ratios and Statistics

IDEANOMICS INC

NASDAQ:IDEX (7/10/2024, 8:07:35 PM)

After market: 0.634 -0.25 (-27.95%)

0.88

-0.04 (-4.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-14
Earnings (Next)08-02
Inst Owners0.12%
Inst Owner Change-0.14%
Ins Owners52.88%
Ins Owner Change0%
Market Cap17.66M
Revenue(TTM)18.38M
Net Income(TTM)-224.30M
Analysts43.33
Price Target1.02 (15.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-98.19%
Min Revenue beat(2)-99.37%
Max Revenue beat(2)-97.01%
Revenue beat(4)0
Avg Revenue beat(4)-93.6%
Min Revenue beat(4)-99.37%
Max Revenue beat(4)-87.75%
Revenue beat(8)0
Avg Revenue beat(8)-83.55%
Revenue beat(12)1
Avg Revenue beat(12)-58.6%
Revenue beat(16)1
Avg Revenue beat(16)-44.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-21.43
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-2.62
FCFYN/A
OCF(TTM)-2.62
OCFYN/A
SpS0.92
BVpS-0.71
TBVpS-3.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -191.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-117.79%
ROA(5y)-94.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.11
Altman-Z -16.65
F-Score2
WACC6.47%
ROIC/WACCN/A
Cap/Depr(3y)67.58%
Cap/Depr(5y)57.59%
Cap/Sales(3y)4.51%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.11%
EPS Next Y58.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-65.32%
Revenue growth 3Y-16.76%
Revenue growth 5Y-47.23%
Sales Q2Q%-77.68%
Revenue Next Year74.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.49%
OCF growth 3YN/A
OCF growth 5YN/A

IDEANOMICS INC / IDEX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IDEANOMICS INC (IDEX) stock?

ChartMill assigns a fundamental rating of 0 / 10 to IDEX.


What is the valuation status for IDEX stock?

ChartMill assigns a valuation rating of 0 / 10 to IDEANOMICS INC (IDEX). This can be considered as Overvalued.


Can you provide the profitability details for IDEANOMICS INC?

IDEANOMICS INC (IDEX) has a profitability rating of 0 / 10.


What is the financial health of IDEANOMICS INC (IDEX) stock?

The financial health rating of IDEANOMICS INC (IDEX) is 0 / 10.


Can you provide the dividend sustainability for IDEX stock?

The dividend rating of IDEANOMICS INC (IDEX) is 0 / 10 and the dividend payout ratio is 0%.